SCHEMBL3660553

SCHEMBL3660553

NC(=O)c1cc(O)ccc1C1CCC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.50
MEN1 O00255 2/20 0.50
MAPT P10636 2/20 0.50
KMT2A Q03164 2/20 0.50
FASN P49327 2/20 0.40
PARP1 P09874 1/20 0.39
TAS1R3 Q7RTX0 2/20 0.38
TAS1R1 Q7RTX1 2/20 0.38
TAS1R2 Q8TE23 2/20 0.38
ALDH1A1 P00352 1/20 0.38
LMNA P02545 1/20 0.38
GAA P10253 1/20 0.38
NFKB1 P19838 1/20 0.38
HTT P42858 1/20 0.38
NFKB2 Q00653 1/20 0.38
RELA Q04206 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
CDC7 O00311 1/20 0.37
CAMKK2 Q96RR4 1/20 0.37
LCK P06239 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3658942 0.93 KDM4E (0.45) KDM4EMEN1MAPTKMT2APARP1
SCHEMBL29490978 0.86 KDM4E (0.50) KDM4EMEN1MAPTKMT2AFASN
SCHEMBL8335954 0.80 MAPT (0.44) KDM4EMEN1MAPTKMT2ATAS1R3
SCHEMBL11806074 0.79 ACMSD (0.53) KDM4EMEN1MAPTKMT2AALDH1A1
SCHEMBL30868260 0.79 MEN1 (0.50) KDM4EMEN1MAPTKMT2AFASN
SCHEMBL4598601 0.79 KDM4E (0.45) KDM4EMEN1MAPTKMT2APARP1
SCHEMBL1667824 0.78 PTGDR2 (0.51) KDM4EMEN1MAPTKMT2APARP1
SCHEMBL12505499 0.77 KDM4E (0.51) KDM4EMEN1MAPTKMT2AALDH1A1
SCHEMBL3376199 0.77 ADRA1A (0.49) KDM4EMEN1MAPTKMT2APARP1
SCHEMBL28182422 0.74 OPRL1 (0.43) KDM4EMEN1MAPTKMT2APARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2234995-A1 LEUKOTRIENE B4 INHIBITORS F. Hoffmann-La Roche AG (CH) 2010-10-06 EP disclosed
WO-2009077385-A1 LEUKOTRIENE B4 INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2009-06-25 WO disclosed